GlassScriptPhysician profile
Brent B Belvin
NPI 1639103047
$2,910.60
in general payments reported to CMS, 2019-2025
40 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,249 · 2020: $328 · 2021: $348 · 2022: $279 · 2023: $320 · 2024: $223 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $544.96 | 2019-2025 | Xtampza |
| Scilex Pharmaceuticals INC. | $217.01 | 2019-2023 | Ztlido |
| Abbott Laboratories | $176.75 | 2019-2020 | |
| Boston Scientific Corporation | $171.88 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $165.98 | 2019-2020 | |
| Abbvie INC. | $132.29 | 2022-2025 | Botox, Ubrelvy |
| Indivior INC. | $124.63 | 2020-2021 | |
| Stimwave Technologies Incorporated | $120.00 | 2019 | |
| Medtronic, INC. | $107.96 | 2022-2023 | Intellis Adaptivestim |
| Forte Bio-Pharma LLC | $102.42 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $96.46 | 2020-2021 | |
| Lundbeck LLC | $91.10 | 2022-2023 | Vyepti |
| Pacira Therapeutics, INC. | $83.70 | 2019 | |
| Pfizer INC. | $77.22 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $53.74 | 2025 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Belvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.